Format

Send to

Choose Destination
J Clin Periodontol. 2015 Aug;42(8):783-788. doi: 10.1111/jcpe.12439. Epub 2015 Aug 26.

Non-surgical treatment of peri-implant mucositis and peri-implantitis at zirconia implants: a prospective case series.

Author information

1
Department of Oral Surgery, Westdeutsche Kieferklinik, Universitätsklinikum Düsseldorf, Düsseldorf, Germany.

Abstract

OBJECTIVES:

To assess the efficacy of non-surgical therapy for the management of peri-implant diseases at a two-piece zirconium implant system.

MATERIAL & METHODS:

Thirty-four patients with 45 implants participated in this study. Seventeen patients (24 implants) were diagnosed with peri-implant mucositis and received mechanical debridement + local antiseptic therapy using chlorhexidine digluconate (MD + CXH), while 17 patients (21 implants) diagnosed with peri-implantitis were assigned to Er:YAG laser therapy. In both groups, post-operative maintenance care included supramucosal plaque removal and local pocket irrigation using CHX. The primary endpoint was defined as disease resolution at 6 months (i.e. absence of bleeding upon probing (BOP) at mucositis sites/absence of BOP and probing pocket depths (PD) ≥6 mm at peri-implantitis sites).

RESULTS:

Resolution of peri-implant mucositis and peri-implantitis was obtained in 9/17 (52.9%) (p = 0.001) and 5/17 (29.4%) (p = 0.02) of the patients respectively.

CONCLUSION:

Non-surgical treatment of either peri-implant mucositis using MD + CHX or peri-implantitis using ERL at zirconia implants was associated with significant short-term clinical improvements. A complete disease resolution, however, was not achieved in the majority of the patients.

KEYWORDS:

Non-surgical therapy; peri-implant diseases; zirconia implants

PMID:
26249545
DOI:
10.1111/jcpe.12439

Supplemental Content

Full text links

Icon for Wiley
Loading ...
Support Center